Improving HPV vaccination rates in underserved communities through communication campaigns
P30 Administrative Supplement for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
This study is working to help more Hispanic, Latino, and African American teens get the HPV vaccine by sharing helpful information in ways that make sense to them, using social media and friends to spread the word.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11142208 on NIH RePORTER |
What this research studies
This research focuses on enhancing HPV vaccination rates among underserved populations, particularly Hispanic, Latino, and African adolescent groups. It aims to address low health literacy and misconceptions about the HPV vaccine through tailored communication strategies. The project will utilize multi-channel campaigns, including social media and peer-to-peer promotion, to disseminate culturally relevant educational materials. Additionally, artificial intelligence will be employed to adapt these materials to better resonate with the target audience.
Who could benefit from this research
Good fit: Ideal candidates for this research include adolescents and young adults aged 10-30 from Hispanic, Latino, and African backgrounds, particularly those with low health literacy regarding HPV.
Not a fit: Patients who are already fully vaccinated against HPV or those outside the targeted age and demographic groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates and improve cancer prevention in underserved communities.
How similar studies have performed: Previous research has shown success in using tailored communication strategies to improve vaccination rates in similar underserved populations.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Lerman, Caryn — University of Southern California
- Study coordinator: Lerman, Caryn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.